In studies of prostate cancer and breast cancer, CD133, also known as Prominin 1, serves as a key surface marker for identifying tumor cells with stem‐like properties, and CD133‐positive circulating tumor cells (CTCs) have shown stem‐like potential [18, 19, 20]. Here, PROM1 is linked to prostate carcinoma.